US Wrap: Reverse convertible issuance slows from dominant providers
Reverse convertibles made up five of the eight new products issued in the US market yesterday, signalling a continued uptick in the structure's popularity. However, it appears that the most aggressive providers are showing more caution than they were earlier in February. Barclays Bank launched just two notes, against its 25-strong offering last Thursday, and ABN Amro put a single note into the market, after issuing 16 in the middle of the month. Citi and Morgan Stanley dipped a toe in the water with a single note each.
Energy stocks continue to be popular, and biotech company Monsanto made its first appearance since January.
Issuer
Product type
Underlying
Pricing date
Maturity date
Barclays Bank
Reverse Convertible
Monsanto
Feb 24 2009
Aug 27 2009
Morgan Stanley
Straddle
S&P 500
Mar-09
Mar 20 2011
HSBC USA INC
Review
S&P 500
Feb 26 2009
Mar 16 2011
HSBC USA INC
Review
S&P 500
Feb 26 2009
Mar 17 2010
Citigroup Funding
Reverse Convertible
Ap
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net
More on Regulation
Don’t mention the rules: the fight against prediction market abuse
For the CFTC to regulate new venues effectively, it must first redefine insider trading
Can the US FRTB revamp make the IMA great again?
Banks are finally presented with a viable internal models framework under Basel III’s market risk rules
UK rethinking tougher capital rules for US bank subsidiaries
US endgame draft would trigger UK Basel III trap floor for foreign banks, but PRA is reviewing
EBA proposes drastic overhaul to supervisory data reporting
Revamp will cut back the number of datapoints and integrate overlapping reports
CFTC wants to regulate prediction markets. Is it up to the task?
Former officials echo state gambling authorities’ concerns over agency’s ability to police betting risks
EBA seeks to allay Simm divergence concerns
EU validator pledges to co-ordinate with global regulators, but retains ability to act alone “if needed”
FRTB models find salvation in US Basel III proposal
Changes to P&L attribution test and NMRFs make IMA viable for US banks, risk managers say
US blows the floors off Basel III
Barr criticises “downward deviations” in US rule; Bowman rejects “blind adherence” to global standards
